Treatment of Cerebral Edema in Intracerebral Hemorrhage with Elevated Intracranial Pressure
Cerebral edema and elevated intracranial pressure (ICP) are serious complications in patients presenting with intracerebral hemorrhage. Managing these conditions requires an evidence-informed approach that accounts for the specific pathophysiology of this population.
Clinical Scenario
This protocol applies to patients with intracerebral hemorrhage who develop elevated intracranial pressure or cerebral edema. Agent selection in this population differs from other causes of raised ICP, and not all commonly used agents are appropriate here.
Treatment Approach (partial overview)
Management centers on intravenous hypertonic sodium solutions as the preferred agent class for ICP reduction and cerebral edema control in this setting. The full protocol specifies administration strategy and the agents that are not recommended in this population.
Complete regimen, dosing strategy, and agent guidance available in the full protocol →
Treatment Goals
Reduction of elevated intracranial pressure and cerebral edema.
References
DOI: 10.1007/s12028-020-00959-7
- We suggest using hypertonic sodium solutions over mannitol for the management of ICP or cerebral edema in patients with intracerebral hemorrhage (conditional recommendation, very low-quality evidence).
- We suggest that either symptom-based bolus dosing or using a targeted sodium concentration is appropriate hypertonic sodium solution administration strategy for the management of elevated ICP or cerebral edema in patients with intracerebral hemorrhage (conditional recommendation, very low-quality evidence).
- While the overall quality of evidence in this area is very low, the panel felt there was enough consistency across published studies to suggest that HTS is effective in reducing ICP elevations and cerebral edema.
View source ↗